NCT00046644

Brief Summary

To elucidate the mechanisms underlying inter-patient variation in response to montelukast, a drug for asthma.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Timeline
Completed

Started Jun 2002

Typical duration for all trials

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2002

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

September 30, 2002

Completed
1 day until next milestone

First Posted

Study publicly available on registry

October 1, 2002

Completed
2.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2005

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2005

Completed
Last Updated

April 17, 2014

Status Verified

April 1, 2014

Enrollment Period

2.9 years

First QC Date

September 30, 2002

Last Update Submit

April 16, 2014

Conditions

AsthmaLung Diseases

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
No eligibility criteria

Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.

Sponsors & Collaborators

Related Publications (1)

  • Duan QL, Gaume BR, Hawkins GA, Himes BE, Bleecker ER, Klanderman B, Irvin CG, Peters SP, Meyers DA, Hanrahan JP, Lima JJ, Litonjua AA, Tantisira KG, Liggett SB. Regulatory haplotypes in ARG1 are associated with altered bronchodilator response. Am J Respir Crit Care Med. 2011 Feb 15;183(4):449-54. doi: 10.1164/rccm.201005-0758OC. Epub 2010 Sep 17.

    PMID: 20851928DERIVED

MeSH Terms

Conditions

AsthmaLung Diseases

Condition Hierarchy (Ancestors)

Bronchial DiseasesRespiratory Tract DiseasesLung Diseases, ObstructiveRespiratory HypersensitivityHypersensitivity, ImmediateHypersensitivityImmune System Diseases

Study Officials

  • John Lima

    Nemours Children's Clinic

Study Design

Study Type
observational
Sponsor Type
OTHER

Study Record Dates

First Submitted

September 30, 2002

First Posted

October 1, 2002

Study Start

June 1, 2002

Primary Completion

May 1, 2005

Study Completion

May 1, 2005

Last Updated

April 17, 2014

Record last verified: 2014-04